ARTICLE | Clinical News
Oralair regulatory update
May 23, 2011 7:00 AM UTC
Stallergenes said Australia's Therapeutic Goods Administration (TGA) approved Oralair to treat grass pollen-induced allergic rhinitis in adult and pediatric patients. The sublingual immunotherapy agai...